BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 29754567)

  • 1. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 6. Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
    Deininger KM; Tran JN; Tsunoda SM; Young GK; Lee YM; Anderson HD; Page Ii RL; Hirsch JD; Aquilante CL
    Pharmacogenomics; 2019 Dec; 20(18):1291-1302. PubMed ID: 31755847
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes about pharmacogenomic testing vary by healthcare specialty.
    Preys CL; Blout Zawatsky CL; Massmann A; Heukelom JV; Green RC; Hajek C; Hickingbotham MR; Zoltick ES; Schultz A; Christensen KD
    Pharmacogenomics; 2023 Jul; 24(10):539-549. PubMed ID: 37458095
    [No Abstract]   [Full Text] [Related]  

  • 9. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.
    Raccor BS; Thompson DK; Thomas C; Hill AK; Shields K; Alcala-Williams I; Cartrette T; Fasinu P; Al-Achi A
    Pharmacogenomics; 2021 Jan; 22(1):13-25. PubMed ID: 33356552
    [No Abstract]   [Full Text] [Related]  

  • 12. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
    McKillip RP; Borden BA; Galecki P; Ham SA; Patrick-Miller L; Hall JP; Hussain S; Danahey K; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Ratain MJ; Meltzer DO; O'Donnell PH
    Clin Pharmacol Ther; 2017 Jul; 102(1):106-114. PubMed ID: 27981566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase.
    Nguyen KA; Patel H; Haggstrom DA; Zillich AJ; Imperiale TF; Russ AL
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):194. PubMed ID: 31623616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization.
    Bar-Peled Y; Denton JJ; Richards JL; Brown D; Worthey E; Strong TV
    Pharmacogenomics; 2024 Mar; 25(4):207-216. PubMed ID: 38506331
    [No Abstract]   [Full Text] [Related]  

  • 18. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
    Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
    Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.
    Dressler LG; Bell GC; Abernathy PM; Ruch K; Denslow S
    Pharmacogenomics; 2019 Apr; 20(6):433-446. PubMed ID: 30983513
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.